A research team at Academia Sinica has developed a key reagent for a pioneering rapid screening test for the COVID-19 coronavirus disease and the technology has been transferred to seven companies, one or two of which will be chosen for possible mass production, James Liao (廖俊智), president of Taiwan's most prestigious research institution, said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares open higher
08/07/2026 09:42 AM - Politics
U.S. announces tariffs, minimum prices on polysilicon imports
08/07/2026 09:40 AM - Society
Air, sea transport disrupted ahead of Typhoon Dolphin
08/06/2026 09:50 PM - Culture
Record 147 Filipinos awarded Taiwan scholarships in 2026
08/06/2026 08:56 PM - Business
Taiwan's inflation stays above 2% for third straight month in July
08/06/2026 08:14 PM